Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.
BioDrugs. 2020 Dec;34(6):713-721. doi: 10.1007/s40259-020-00451-w.
BioDrugs. 2020.
PMID: 33105016
Clinical Trial.